摘要
可改善转移性耐去势前列腺癌患者总生存期的新药物的有效性,使得使用它们提高累计存活率成为可能。这种新的药物已被管理作为第三线治疗药物,而之前它们被当作二线药物。但其疗效还没有得到临床试验数据的证明,使用最佳序列以最大限度地提高治疗效果的交叉耐药性已经得到证实。此外,把新的激素药物应用于化疗患者以及把新的化疗药物应用于激素敏感者使得情况更加复杂。本文批判性地总结讨论了有关连续使用新药物的数据,并讨论了他们在治疗转移性耐去势前列腺癌的最佳定位。
关键词: 耐去势前列腺癌,序列,一线药物,二线药物,多烯紫杉醇,醋酸阿比特龙,cabazitaxel, enzalutamide
图形摘要
Current Drug Targets
Title:Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?
Volume: 17 Issue: 11
Author(s): Orazio Caffo, Andrea Lunardi, Chiara Trentin, Francesca Maines, Antonello Veccia, Enzo Galligioni
Affiliation:
关键词: 耐去势前列腺癌,序列,一线药物,二线药物,多烯紫杉醇,醋酸阿比特龙,cabazitaxel, enzalutamide
摘要: The availability of new drugs capable of improving the overall survival of patients with metastatic castration-resistant prostate cancer has led to the possibility of using them sequentially in the hope of obtaining a cumulative survival benefit. The new agents have already been administered as third-line treatments in patients who have previously received them as second line in everyday clinical practice, but the efficacy of this practice is not yet supported by clinical trial data, and evidence of possible cross-resistance has reinforced the debate concerning the best sequence to use in order to maximise the benefit. Furthermore, the situation is further complicated by the possibility of administering new hormonal agents to chemotherapy-naïve patients, and novel chemotherapeutic agents to hormone-sensitive patients. This article critically reviews the available data concerning the sequential use of new drugs, and discusses the real evidence concerning their optimal positioning in the therapeutic strategy of metastatic castration-resistant prostate cancer.
Export Options
About this article
Cite this article as:
Orazio Caffo, Andrea Lunardi, Chiara Trentin, Francesca Maines, Antonello Veccia, Enzo Galligioni , Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?, Current Drug Targets 2016; 17 (11) . https://dx.doi.org/10.2174/1389450117666160101121317
DOI https://dx.doi.org/10.2174/1389450117666160101121317 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
miR-149 as a Potential Molecular Target for Cancer
Current Medicinal Chemistry Enhanced Gene Delivery and/or Efficacy by Functional Peptide and Protein
Current Topics in Medicinal Chemistry Anticancer Agents: VTA or VDA
Current Bioactive Compounds Nerve Growth Factor: Early Studies and Recent Clinical Trials
Current Neuropharmacology Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity
Current Protein & Peptide Science Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review
Current Medicinal Chemistry ADAM Metalloproteinases as Potential Drug Targets
Current Medicinal Chemistry Chip-Based High Throughput Screening of Herbal Medicines
Combinatorial Chemistry & High Throughput Screening SUBJECT INDEX TO VOLUME 1
Current Drug Safety Proteasomes as Drug Targets
Current Drug Targets Function of miRNA in Controlling Drug Resistance of Human Cancers
Current Drug Targets Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
Anti-Cancer Agents in Medicinal Chemistry DNA Vaccination in Oncology: Current Status, Opportunities and Perspectives
Current Clinical Pharmacology Imaging Cellular Receptors in Breast Cancers: An Overview
Current Pharmaceutical Biotechnology Surgical Strategies for Fertility Preservation in Women with Cancer
Current Women`s Health Reviews A Review on the Techniques for Characterizing and Predicting Human Genomic DNA Methylation
Current Bioinformatics Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Recent Applications of Artificial Intelligence in Early Cancer Detection
Current Medicinal Chemistry Viral Vectors for Cancer Gene Therapy: Viral Dissemination and Tumor Targeting
Current Gene Therapy Nongenomic Actions of Retinoids: Role of Nur77 and RXR in the Regulation of Apoptosis and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry